Management of neuronopathic Gaucher disease: revised recommendations.
J Inherit Metab Dis
; 32(5): 660-664, 2009 Oct.
Article
en En
| MEDLINE
| ID: mdl-19655269
ABSTRACT
The original guidelines drawn up for the management of the neuronopathic forms of Gaucher disease were felt to be in need of revision; in particular, the role of high-dose enzyme replacement therapy (120 IU/kg of body weight every 2 weeks) in stabilizing neurological disease. The existing published evidence was analysed; it was concluded that it did not support the role of high-dose ERT, although this might be required to treat severe visceral disease.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedad de Gaucher
/
Directrices para la Planificación en Salud
Tipo de estudio:
Diagnostic_studies
/
Guideline
Límite:
Humans
Idioma:
En
Revista:
J Inherit Metab Dis
Año:
2009
Tipo del documento:
Article
País de afiliación:
Reino Unido